Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| BABYNOSTICS | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
The prediction of preterm birth is beneficial because it initiates early treatment to minimize risk. It defines a population at risk to provide particular treatment and may lead us to a better understanding the mechanisms of preterm birth. The understanding of the mechanisms and etiology consequently leads to the possibility of early intervention and effective management aiming at preventing preterm birth. Five most common interventions for preventing and treating preterm birth are antibiotics, cervical cerclage, bed rest, progesterone, and tocolytic therapy. However, there are insufficient evidence showing the efficacy of cerclage and bed rest; antibiotics may only delay but not prevent the preterm birth; the use of certain tocolytics needs to be considered against the possible adverse effects. The early detection of pregnant women with high risk for preterm delivery would be the ideal solution to prevent preterm birth. However, to date, there is inadequate literature and little knowledge of diagnosis, treatment, prevention and prediction of preterm birth.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Cervical length | Cervical length <15, 20, 25 mm | 6-12 months |
| Biomarkers (serum) | subjects with feral fibronectin ≥50 ng/mL, >10 mg/L of cervical phIGFBP1; elevated Interleukin-6 as compared to term birth; significantly present of other biomarkers. | 6-12 months |
| Lipid analysis (serum and DBS) | Lipid profiles of preterm birth compared to term birth. | 6-12 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Pregnancy women
Not provided
Estimated 600 symptomatic women aged ≥ 18 years with pregnancy at 24 to 28 weeks of gestation.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jillian De Leon | Contact | jillian.deleon@sprim.com | ||
| Orawan Suitthimeathegorn | Contact | orawan.suitthimeathegorn@sprim.com |
| Name | Affiliation | Role |
|---|---|---|
| Mariano Diosdado V., MD | MD | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Perinatal Association of the Philippines | Recruiting | Quezon | Brgy Malaya | Philippines |
Not provided
| ID | Term |
|---|---|
| D047928 | Premature Birth |
| ID | Term |
|---|---|
| D007752 | Obstetric Labor, Premature |
| D007744 | Obstetric Labor Complications |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
Not provided
Not provided
Not provided
Saliva, cervicovaginal fluid, serum and dried blood spot
| D000091642 | Urogenital Diseases |